Literature DB >> 18718113

Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.

Jasjeet K Sahni1, Shruti Chopra, Farhan J Ahmad, Roop K Khar.   

Abstract

In recent years, researchers have been working extensively on various novel properties of polymers to develop increased efficiency of drug delivery and improve bioavailability of various drug molecules, especially macromolecules. Chitosan, a naturally occurring polysaccharide, because of its protonated/polymeric nature, provides effective and safe absorption of peptide and protein drugs. Its transmucosal absorption is, however, limited to acidic media because of its strong intermolecular hydrogen bonds. A new partially quaternized chitosan derivative, N-trimethyl chitosan chloride (TMC), has been synthesized with improved solubility, safety and effectiveness as an absorption enhancer at neutral pH and in aqueous environment. It enhances the absorption, especially of peptide drugs, by reversible opening of tight junctions in between epithelial cells, thereby facilitating the paracellular diffusion of peptide drugs. This derivative thus opens new perspectives as a biomaterial for various pharmaceutical applications/drug delivery systems. This review deals with the potential use of the quaternized chitosan derivative as a permeation enhancer for the mucosal delivery of macromolecular drugs along with its other biomedical applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718113     DOI: 10.1211/jpp.60.9.0001

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

Review 1.  Advances in Infectious Disease Vaccine Adjuvants.

Authors:  Jingyi Fan; Shengbin Jin; Lachlan Gilmartin; Istvan Toth; Waleed M Hussein; Rachel J Stephenson
Journal:  Vaccines (Basel)       Date:  2022-07-13

2.  Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge.

Authors:  Alex J Mann; Nicolas Noulin; Andrew Catchpole; Koert J Stittelaar; Leon de Waal; Edwin J B Veldhuis Kroeze; Michael Hinchcliffe; Alan Smith; Emanuele Montomoli; Simona Piccirella; Albert D M E Osterhaus; Alastair Knight; John S Oxford; Giulia Lapini; Rebecca Cox; Rob Lambkin-Williams
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

3.  Curdlan sulfate-O-linked quaternized chitosan nanoparticles: potential adjuvants to improve the immunogenicity of exogenous antigens via intranasal vaccination.

Authors:  Shu Zhang; Shengshi Huang; Lu Lu; Xinlei Song; Pingli Li; Fengshan Wang
Journal:  Int J Nanomedicine       Date:  2018-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.